Gainers
-
Autodesk, Inc. (NASDAQ: ADSK) shares
are up 11 percent following a fourth quarter earnings beat. Adjusted earnings came in at a loss of 9 cents, beating estimates
by 2 cents. Sales came in at $554 million, beating estimates by $9 million. Subscription annual recurring revenue was $1.18
billion, up 106 percent year-over-year.
-
Bojangles Inc (NASDAQ: BOJA) shares are
up 8 percent after reporting a fourth quarter earnings and sales beat. Adjusted earnings came in at 23 cents, beating estimates
by 5 cents. Sales came in at $148 million, beating estimates by $2 million.
-
Medifast Inc (NYSE: MED) shares are up 9
percent following a fourth quarter earnings and sales beat. Earnings came in at 60 cents per share, beating estimates by 12
cents. Sales came in at $78 million, topping estimates by $5 million. The company issued strong first quarter and FY18
guidance.
-
H & R Block (NYSE: HRB) shares are up 8
percent after reporting a third quarter earnings and sales beat. Adjusted earnings came in at a loss of $1.16, beating
estimates by 13 cents. Sales came in at $488 million, beating estimates by $29 million.
Losers
-
Carvana Co (NYSE: CVNA) shares are down
10 percent after reporting a larger than expected fourth quarter loss. Adjusted earnings came in at a loss of 36 cents per
share, missing estimates by 2 cents. Sales fell short of estimates by $4 million, coming in at $265 million.
-
AeroVironment, Inc. (NASDAQ: AVAV)
shares are down 8 percent after issuing weak FY18 EPS guidance despite reporting a fourth quarter sales beat. The company also
reported it has won a $44.5 million Puma AE UAS contract from a major country in the Middle East.
-
Urban Outfitters, Inc. (NASDAQ: URBN)
shares are down 7 percent despite reporting a fourth quarter earnings and sales beat. Comps were also up 4 percent in the
quarter.
-
Editas Medicine Inc (NASDAQ: EDIT)
shares are down 5 percent following a fourth quarter earnings miss. Collaboration R&D sales came in at $3.7 million,
missing estimates by $400,000.
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.